cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
AA366429 | Pancreas | .e | 803 to 939 | 1 to 137 | 137/137 (100 %) | 0 diff (100 %id) | |||
AB097026 | lung | .a | 391 to 2171 | 1 to 1781 | 1781/1781 (100 %) | 3 diff (99.9 %id) | |||
AL157442 | uterus | .e | 755 to 1453 | 1 to 699 | tiling clone, available from DKFZ, AAA | 699/699 (100 %) | 2 diff (99.8 %id) | ||
CB152351 | brain | .a | 494 to 1147 | 1 to 654 | 654/654 (100 %) | 0 diff (100 %id) | |||
BC041788 | Prostate, adenocarcinoma. | .a | 357 to 2171 | 1 to 1815 | available from MGC, AAA | 1815/1815 (100 %) | 4 diff (99.8 %id) | ||
BC084553 | Pancreas, ductal carcinoma | .a | 466 to 2170 | 1 to 1705 | available from MGC, AAA | 1705/1705 (100 %) | 1 diff (100.0 %id) | ||
BQ309687 | breast | .b | 1054 to 1529 | 1 to 476 | 476/476 (100 %) | 5 diff (99.0 %id) | |||
BQ341003 | nervous_normal | .b | 1068 to 1661 | 1 to 593 | 593/593 (100 %) | 5 diff (99.2 %id) | |||
BQ341004 | nervous_normal | .b | 1061 to 1673 | 1 to 612 | 612/621 (98 %) | 10 diff (98.4 %id) | |||
DA072420 | cerebellum | .a | 399 to 973 | 2 to 576 | capped | 575/575 (100 %) | 0 diff (100 %id) | ||
DA090782 | cerebellum | .a | 398 to 950 | 2 to 554 | capped | 553/553 (100 %) | 0 diff (100 %id) | ||
DA130734 | alzheimer cortex | .a | 390 to 946 | 2 to 558 | capped | 557/557 (100 %) | 0 diff (100 %id) | ||
DA139536 | alzheimer cortex | .a | 331 to 950 | 2 to 621 | capped | 620/620 (100 %) | 0 diff (100 %id) | ||
DA353320 | substantia nigra | .a | 399 to 970 | 2 to 573 | capped | 572/572 (100 %) | 0 diff (100 %id) | ||
DA367856 | subthalamic nucleus | .a | 657 to 1139 | 2 to 484 | capped | 483/483 (100 %) | 0 diff (100 %id) | ||
DA371983 | thalamus | .a | 359 to 908 | 2 to 551 | capped | 550/550 (100 %) | 0 diff (100 %id) | ||
DA382613 | thalamus | .a | 314 to 836 | 2 to 524 | tiling clone, capped | 523/527 (99 %) | 1 diff (99.9 %id) | ||
F03245 | brain, total brain | .b | 1812 to 2110 | 299 to 1 | 299/304 (98 %) | 1 diff (99.7 %id) | |||
F06973 | brain, total brain | .b | 1124 to 1487 | 1 to 364 | 364/364 (100 %) | 1 diff (99.8 %id) | |||
BX425772 | neuroblastoma | .c | 100 to 770 | 5 to 669 | 665/669 (99 %) | 45 diff (93.3 %id) | |||
BX446036 | neuroblastoma | .c | 90 to 898 | 1 to 803 | 803/813 (98 %) | 27 diff (96.7 %id) | |||
CN418016 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 1185 to 1936 | 1 to 753 | 753/753 (100 %) | 6 diff (99.3 %id) | |||
CN418017 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 719 to 1446 | 1 to 728 | 728/728 (100 %) | 2 diff (99.8 %id) | |||
CN418018 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .a | 867 to 1510 | 1 to 644 | 644/644 (100 %) | 2 diff (99.7 %id) | |||
CN418022 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .a | 414 to 628 | 1 to 215 | 215/215 (100 %) | 0 diff (100 %id) | |||
CN418028 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .a | 405 to 537 | 1 to 133 | 133/133 (100 %) | 0 diff (100 %id) | |||
BX375863 | Neuroblastoma Cot 25-normalized | .a | 1016 to 2061 | 1 to 1040 | 1040/1097 (94 %) | 10 diff (99.1 %id) | |||
AL541827 | placenta | .c | 100 to 1051 | 1 to 944 | fully sequenced, | 944/944 (100 %) | 13 diff (98.7 %id) | ||
AL569119 | placenta | .c | 1021 to 1816 | 872 to 77 | fully sequenced, | 796/872 (91 %) | 2 diff (99.8 %id) | ||
BX424636 | brain, fetal brain | .a | 675 to 1548 | 1 to 867 | 869/907 (95 %) | 22 diff (97.6 %id) | |||
BX441449 | brain, fetal brain | .a | 674 to 1571 | 1 to 898 | tiling clone, | 898/898 (100 %) | 6 diff (99.4 %id) | ||
BX444919 | brain, fetal brain | .a | 1129 to 2137 | 1006 to 1 | 1009/1047 (96 %) | 26 diff (97.6 %id) | |||
BX444920 | brain, fetal brain | .a | 674 to 1663 | 1 to 981 | 981/1071 (91 %) | 13 diff (98.8 %id) | |||
AL545865 | placenta, Placenta Cot 25-normalized | .a | 636 to 1333 | 1 to 698 | fully sequenced, | 698/698 (100 %) | 7 diff (99.0 %id) | ||
AL571424 | placenta, Placenta Cot 25-normalized | .a | 1272 to 2139 | 866 to 1 | fully sequenced, | 866/866 (100 %) | 7 diff (99.2 %id) | ||
AL550645 | placenta, Placenta Cot 25-normalized | .a | 828 to 1446 | 1 to 619 | 619/956 (64 %) | 0 diff (100 %id) | |||
AL574451 | placenta, Placenta Cot 25-normalized | .a | 1429 to 2107 | 716 to 27 | 690/1061 (65 %) | 0 diff (100 %id) | |||
AL555137 | placenta | .e | 1140 to 1437 | 301 to 1 | fully sequenced, | 301/301 (100 %) | 6 diff (98.1 %id) | ||
AL555138 | placenta | .e | 861 to 1450 | 1 to 590 | fully sequenced, | 590/590 (100 %) | 5 diff (99.2 %id) | ||
AL555555 | placenta | .a | 695 to 1333 | 1 to 640 | fully sequenced, | 640/640 (100 %) | 2 diff (99.7 %id) | ||
AL578030 | placenta | .a | 1272 to 2133 | 872 to 8 | fully sequenced, | 865/872 (99 %) | 0 diff (100 %id) | ||
AL560601 | B cells from Burkitt lymphoma | .a | 375 to 1323 | 1 to 946 | fully sequenced, | 946/946 (100 %) | 9 diff (99.1 %id) | ||
AL582013 | B cells from Burkitt lymphoma | .a | 1272 to 2132 | 860 to 1 | fully sequenced, | 860/860 (100 %) | 6 diff (99.4 %id) | ||
BX443810 | fetal liver, Liver | .b | 485 to 1223 | 1 to 758 | 758/880 (86 %) | 39 diff (95.6 %id) | |||
BX445201 | fetal liver, Liver | .b | 1073 to 2028 | 955 to 6 | tiling clone, | 950/1011 (93 %) | 13 diff (98.8 %id) | ||
BX445202 | fetal liver, Liver | .b | 485 to 1490 | 1 to 1001 | tiling clone, | 1001/1037 (96 %) | 16 diff (98.5 %id) | ||
EC448536 | Prostate | .a | 1308 to 1391 | 84 to 1 | 84/84 (100 %) | 0 diff (100 %id) | |||
EC579237 | Prostate | .e | 1026 to 1139 | 1 to 114 | 114/114 (100 %) | 0 diff (100 %id) | |||
CD674918 | eye, lens | .e | 805 to 1366 | 1 to 562 | 562/562 (100 %) | 0 diff (100 %id) | |||
R70237 | breast | .f | 806 to 1141 | 342 to 1 | 342/343 (99 %) | 7 diff (98.0 %id) | |||
R70274 | breast | .f | 87 to 564 | 1 to 496 | 427/498 (85 %) | 22 diff (95.6 %id) | |||
R73412 | breast | .f | 87 to 409 | 1 to 324 | tiling clone, | 324/324 (100 %) | 2 diff (99.4 %id) | ||
R73413 | breast | .f | 670 to 1145 | 479 to 1 | tiling clone, | 479/484 (98 %) | 18 diff (96.3 %id) | ||
AA070917 | .a | 1725 to 2169 | 445 to 1 | 445/446 (99 %) | 5 diff (98.9 %id) | ||||
AA071024 | .a | 887 to 1349 | 1 to 461 | 461/463 (99 %) | 5 diff (99.0 %id) | ||||
AA464466 | ovarian tumor, ovary | .e | 558 to 868 | 1 to 311 | tiling clone, | 311/311 (100 %) | 15 diff (95.2 %id) | ||
AI139915 | .e | 1280 to 1454 | 195 to 21 | tiling clone, AAA | 175/175 (100 %) | 0 diff (100 %id) | |||
AI627999 | poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus | .e | 1280 to 1452 | 173 to 1 | 173/173 (100 %) | 0 diff (100 %id) | |||
AI818748 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .c | 91 to 390 | 1 to 300 | Submitted on the opposite strand | 300/300 (100 %) | 2 diff (99.4 %id) | ||
AW082684 | pooled | .h | 1 to 629 | 1 to 629 | tiling clone, | Submitted on the opposite strand | 629/631 (99 %) | 2 diff (99.7 %id) | |
AW150045 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .e | 1370 to 1453 | 100 to 17 | AAA | 84/84 (100 %) | 0 diff (100 %id) | ||
AW300997 | colon, moderately differentiated adenocarcinoma | .e | 1282 to 1452 | 197 to 27 | AAA | 171/171 (100 %) | 0 diff (100 %id) | ||
AW245504 | lung, small cell carcinoma | .a | 630 to 1116 | 10 to 496 | 487/496 (98 %) | 0 diff (100 %id) | |||
AW245947 | lung, small cell carcinoma | .a | 1654 to 2171 | 529 to 11 | AAA | 519/519 (100 %) | 3 diff (99.5 %id) | ||
AW519067 | adenocarcinoma, Pancreas | .a | 437 to 780 | 1 to 344 | Submitted on the opposite strand | 344/344 (100 %) | 0 diff (100 %id) | ||
AW468977 | poorly differentiated adenocarcinoma withsignet ring cell features, stomach | .c | 133 to 432 | 1 to 300 | Submitted on the opposite strand | 300/300 (100 %) | 2 diff (99.4 %id) | ||
BE292921 | adenocarcinoma cell line, colon | .a | 830 to 1535 | 1 to 701 | 701/724 (96 %) | 12 diff (98.4 %id) | |||
BE272469 | adenocarcinoma cell line, ovary | .f | 1 to 570 | 30 to 599 | tiling clone, | 570/599 (95 %) | 8 diff (98.7 %id) | ||
BE271624 | adenocarcinoma cell line, ovary | .a | 840 to 1777 | 1 to 927 | 927/1010 (91 %) | 44 diff (95.7 %id) | |||
BE315332 | adenocarcinoma cell line, ovary | .a | 850 to 1486 | 1 to 636 | 636/639 (99 %) | 3 diff (99.6 %id) | |||
BE272763 | Kidney, renal cell adenocarcinoma | .a | 884 to 1432 | 1 to 549 | 549/549 (100 %) | 0 diff (100 %id) | |||
BE531284 | adenocarcinoma, Pancreas | .b | 1116 to 1917 | 1 to 801 | 801/947 (84 %) | 28 diff (97.1 %id) | |||
BE615144 | adenocarcinoma, Pancreas | .b | 1114 to 1911 | 1 to 795 | 795/800 (99 %) | 28 diff (96.5 %id) | |||
BF436859 | Prostate | .a | 1 to 321 | 321 to 1 | tiling clone, | 321/321 (100 %) | 0 diff (100 %id) | ||
BE742688 | adenocarcinoma cell line, ovary | .a | 838 to 1488 | 1 to 652 | 652/652 (100 %) | 8 diff (98.8 %id) | |||
BE745065 | adenocarcinoma cell line, ovary | .a | 850 to 1651 | 1 to 798 | 798/949 (84 %) | 28 diff (97.1 %id) | |||
BE881573 | large cell carcinoma, undifferentiated, lung | .a | 861 to 1589 | 1 to 731 | 731/784 (93 %) | 31 diff (96.1 %id) | |||
BE905028 | epithelioid carcinoma, Pancreas | .a | 1049 to 1825 | 1 to 769 | 769/811 (94 %) | 26 diff (96.8 %id) | |||
BE745388 | adenocarcinoma cell line, ovary | .a | 1123 to 1872 | 1 to 745 | 745/817 (91 %) | 8 diff (99.1 %id) | |||
BC007843 | Brain, neuroblastoma | .a | 356 to 2169 | 1856 to 3669 | tiling clone, available from MGC, AAA | 1814/3660 (49 %) | 7 diff (99.9 %id) | ||
BF525489 | brain, glioblastoma with EGFR amplification | .a | 1069 to 1780 | 1 to 707 | 707/756 (93 %) | 12 diff (98.5 %id) | |||
BF970341 | adrenal cortex carcinoma, cell line, adrenal gland | .a | 931 to 1732 | 1 to 795 | 795/795 (100 %) | 19 diff (97.7 %id) | |||
BG110093 | Bone, osteosarcoma, cell line | .a | 1070 to 1822 | 1 to 747 | 747/813 (91 %) | 18 diff (97.8 %id) | |||
BF981490 | duodenal adenocarcinoma, cell line, small intestine | .a | 1045 to 1891 | 25 to 861 | 837/1014 (82 %) | 42 diff (95.9 %id) | |||
BG258777 | embryonal carcinoma, cell line, testis | .e | 1 to 624 | 1 to 625 | tiling clone, | 625/625 (100 %) | 11 diff (98.3 %id) | ||
BG284189 | adenocarcinoma, cell line, Prostate | .a | 895 to 1571 | 1 to 677 | 677/677 (100 %) | 1 diff (99.9 %id) | |||
BG325344 | Kidney, renal cell adenocarcinoma | .c | 26 to 396 | 1 to 366 | tiling clone, | 366/366 (100 %) | 7 diff (98.1 %id) | ||
BG485027 | lung | .a | 1117 to 1850 | 1 to 735 | 735/777 (94 %) | 21 diff (97.3 %id) | |||
BG491444 | amelanotic melanoma, cell line, skin | .c | 35 to 410 | 1 to 383 | 383/403 (95 %) | 23 diff (94.3 %id) | |||
BG491992 | amelanotic melanoma, cell line, skin | .c | 1227 to 1891 | 676 to 1 | 676/742 (91 %) | 26 diff (96.5 %id) | |||
BG742139 | skin | .a | 795 to 1606 | 1 to 810 | 810/810 (100 %) | 4 diff (99.6 %id) | |||
BG749941 | eye, normal pigmented retinal epithelium | .a | 847 to 1687 | 1 to 843 | 843/846 (99 %) | 16 diff (98.2 %id) | |||
BG746886 | adenocarcinoma cell line, colon | .a | 841 to 1649 | 1 to 809 | 809/809 (100 %) | 2 diff (99.8 %id) | |||
BG751575 | eye, normal pigmented retinal epithelium | .a | 822 to 1482 | 1 to 661 | 661/661 (100 %) | 2 diff (99.7 %id) | |||
BG910165 | anaplastic oligodendroglioma with 1p/19qloss, brain | .a | 889 to 1695 | 1 to 806 | 806/806 (100 %) | 9 diff (98.9 %id) | |||
BI117284 | lung, small cell carcinoma | .a | 826 to 1515 | 1 to 690 | 690/690 (100 %) | 3 diff (99.6 %id) | |||
BI161113 | epithelioid carcinoma cell line, Pancreas | .a | 1191 to 1921 | 1 to 730 | 730/730 (100 %) | 6 diff (99.2 %id) | |||
BI711275 | insulinoma, Pancreas | .a | 2021 to 2171 | 168 to 18 | AAA | 151/151 (100 %) | 1 diff (99.4 %id) | ||
BI711685 | insulinoma, Pancreas | .a | 1406 to 1933 | 1 to 528 | 528/528 (100 %) | 1 diff (99.9 %id) | |||
BI830286 | brain, medulla | .b | 29 to 365 | 1 to 339 | 339/481 (70 %) | 7 diff (98.6 %id) | |||
BI818608 | pooled brain, lung, testis | .a | 1098 to 1890 | 1 to 794 | 794/794 (100 %) | 7 diff (99.2 %id) | |||
BI819782 | pooled brain, lung, testis | .a | 1098 to 1947 | 1 to 846 | 846/863 (98 %) | 8 diff (99.1 %id) | |||
BI756533 | brain | .a | 1045 to 1812 | 1 to 769 | 769/769 (100 %) | 8 diff (99.0 %id) | |||
BI457549 | epithelioid carcinoma cell line, Pancreas | .a | 1207 to 1947 | 1 to 736 | 736/736 (100 %) | 11 diff (98.6 %id) | |||
BI870366 | adenocarcinoma, cell line, Liver | .b | 1122 to 1835 | 1 to 714 | 714/714 (100 %) | 3 diff (99.6 %id) | |||
BM015814 | breast, mammary adenocarcinoma, cell line | .a | 1031 to 1886 | 1 to 863 | 863/865 (99 %) | 17 diff (98.1 %id) | |||
BM015501 | breast, mammary adenocarcinoma, cell line | .a | 1048 to 1886 | 1 to 840 | 840/843 (99 %) | 19 diff (97.8 %id) | |||
BM016322 | breast, mammary adenocarcinoma, cell line | .a | 805 to 1695 | 1 to 897 | 897/898 (99 %) | 23 diff (97.5 %id) | |||
BM019593 | astrocytoma grade IV, cell line, brain | .a | 993 to 1891 | 1 to 903 | 903/910 (99 %) | 29 diff (96.9 %id) | |||
BQ108667 | astrocytoma grade IV, cell line, brain | .a | 994 to 1697 | 1 to 704 | 704/704 (100 %) | 4 diff (99.5 %id) | |||
BM009740 | amelanotic melanoma, cell line, skin | .a | 1191 to 1963 | 1 to 774 | 774/776 (99 %) | 4 diff (99.5 %id) | |||
BM011239 | brain, neuroblastoma, cell line | .a | 804 to 1681 | 1 to 877 | 877/878 (99 %) | 20 diff (97.8 %id) | |||
BM013150 | brain, neuroblastoma, cell line | .a | 804 to 1553 | 1 to 762 | 762/780 (97 %) | 17 diff (97.9 %id) | |||
BM464495 | leiomyosarcoma, uterus | .a | 936 to 1904 | 1 to 976 | 976/1101 (88 %) | 33 diff (97.1 %id) | |||
BM564773 | eye, retinoblastoma | .a | 911 to 1590 | 40 to 721 | 682/1039 (65 %) | 14 diff (98.7 %id) | |||
BM479315 | duodenal adenocarcinoma, cell line, small intestine | .a | 841 to 1619 | 1 to 781 | 781/1069 (73 %) | 6 diff (99.5 %id) | |||
BM906291 | ovary (pool of 3) | .a | 705 to 1427 | 12 to 741 | 730/1038 (70 %) | 28 diff (97.4 %id) | |||
BM562921 | duodenal adenocarcinoma, cell line, small intestine | .a | 830 to 1739 | 1 to 916 | 916/1011 (90 %) | 13 diff (98.8 %id) | |||
BM548911 | duodenal adenocarcinoma, cell line, small intestine | .a | 1070 to 2018 | 1 to 959 | 959/1045 (91 %) | 19 diff (98.2 %id) | |||
BM922225 | pooled brain, lung, testis | .a | 748 to 1661 | 1 to 919 | 919/1038 (88 %) | 8 diff (99.3 %id) | |||
BQ268391 | insulinoma, Pancreas | .a | 1997 to 2171 | 192 to 18 | AAA | 175/175 (100 %) | 1 diff (99.5 %id) | ||
BQ270332 | insulinoma, Pancreas | .a | 1388 to 1892 | 1 to 505 | 505/505 (100 %) | 5 diff (99.1 %id) | |||
BQ029736 | lung, Metastatic Chondrosarcoma | .e | 1287 to 1453 | 185 to 19 | AAA | 167/167 (100 %) | 0 diff (100 %id) | ||
BM997984 | lung, Metastatic Chondrosarcoma | .e | 812 to 1453 | 660 to 19 | AAA | 642/642 (100 %) | 0 diff (100 %id) | ||
BQ436463 | epithelioid carcinoma, Pancreas | .a | 597 to 1446 | 1 to 862 | 862/887 (97 %) | 12 diff (98.7 %id) | |||
BQ613881 | insulinoma, Pancreas | .a | 1727 to 2171 | 462 to 18 | fully sequenced, AAA | 445/445 (100 %) | 1 diff (99.8 %id) | ||
BQ631116 | insulinoma, Pancreas | .a | 1388 to 1757 | 1 to 370 | fully sequenced, | 370/370 (100 %) | 5 diff (98.7 %id) | ||
BU071773 | insulinoma, Pancreas | .a | 1388 to 1717 | 1 to 330 | fully sequenced, | 330/330 (100 %) | 5 diff (98.5 %id) | ||
BU073295 | insulinoma, Pancreas | .a | 1687 to 2171 | 503 to 18 | fully sequenced, AAA | 486/486 (100 %) | 3 diff (99.4 %id) | ||
BQ883889 | ductal carcinoma, cell line, Pancreas | .a | 931 to 1870 | 1 to 947 | 947/955 (99 %) | 31 diff (96.8 %id) | |||
BU197286 | epidermoid carcinoma, cell line, salivary gland | .a | 1033 to 1926 | 1 to 899 | 899/902 (99 %) | 17 diff (98.2 %id) | |||
BU167851 | melanotic melanoma, cell line, skin | .a | 808 to 1698 | 1 to 896 | 896/897 (99 %) | 20 diff (97.8 %id) | |||
BQ879056 | melanotic melanoma, cell line, skin | .a | 808 to 1682 | 1 to 880 | 880/881 (99 %) | 9 diff (99.0 %id) | |||
BQ877819 | melanotic melanoma, cell line, skin | .a | 1250 to 2083 | 1 to 845 | AAA | 845/951 (88 %) | 19 diff (98.1 %id) | ||
BU177652 | melanotic melanoma, cell line, skin | .a | 808 to 1690 | 1 to 895 | 895/911 (98 %) | 20 diff (97.9 %id) | |||
BU166656 | melanotic melanoma, cell line, skin | .a | 1302 to 2054 | 1 to 761 | AAA | 761/926 (82 %) | 16 diff (98.3 %id) | ||
BU172077 | adenocarcinoma, Pancreas | .a | 513 to 1173 | 1 to 664 | 664/963 (68 %) | 12 diff (98.8 %id) | |||
BU188757 | melanotic melanoma, cell line, skin | .a | 1250 to 2039 | 1 to 804 | 804/928 (86 %) | 27 diff (97.1 %id) | |||
BU172237 | melanotic melanoma, cell line, skin | .a | 371 to 1038 | 34 to 701 | 668/1028 (64 %) | 12 diff (98.9 %id) | |||
BQ431835 | melanotic melanoma, skin | .a | 826 to 1509 | 1 to 687 | 687/843 (81 %) | 9 diff (99.0 %id) | |||
BQ880682 | dorsal root ganglia | .c | 221 to 978 | 1 to 761 | 761/1008 (75 %) | 17 diff (98.4 %id) | |||
BQ721461 | sympathetic trunk | .e | 800 to 1453 | 1 to 656 | AAA | 656/656 (100 %) | 4 diff (99.4 %id) | ||
BQ879900 | epidermoid carcinoma, cell line, salivary gland | .a | 710 to 1446 | 1 to 740 | 740/898 (82 %) | 9 diff (99.0 %id) | |||
BU174167 | melanotic melanoma, cell line, skin | .a | 808 to 1676 | 1 to 869 | 869/869 (100 %) | 11 diff (98.8 %id) | |||
BU838891 | melanotic melanoma, cell line, skin | .a | 1277 to 2039 | 1 to 764 | 764/926 (82 %) | 17 diff (98.2 %id) | |||
BQ683223 | melanotic melanoma, cell line, skin | .a | 808 to 1689 | 1 to 899 | 899/912 (98 %) | 30 diff (96.8 %id) | |||
BQ680715 | melanotic melanoma, cell line, skin | .a | 808 to 1630 | 1 to 830 | 830/932 (89 %) | 31 diff (96.7 %id) | |||
BQ679688 | melanotic melanoma, cell line, skin | .a | 808 to 1596 | 1 to 795 | 795/911 (87 %) | 14 diff (98.5 %id) | |||
BQ648539 | hepatocellular carcinoma, cell line, Liver | .h | 579 to 1344 | 1 to 782 | exact | tiling clone, | 782/907 (86 %) | 32 diff (96.5 %id) | |
BQ678145 | melanotic melanoma, cell line, skin | .a | 808 to 1669 | 1 to 874 | 874/943 (92 %) | 29 diff (97.0 %id) | |||
BQ673268 | epidermoid carcinoma, cell line, salivary gland | .a | 1103 to 1995 | 1 to 908 | 908/933 (97 %) | 38 diff (96.0 %id) | |||
BQ706845 | Spleen | .a | 1085 to 1892 | 1 to 814 | 814/983 (82 %) | 18 diff (98.2 %id) | |||
BQ708671 | Spleen | .a | 1084 to 1874 | 18 to 818 | 801/988 (81 %) | 23 diff (97.7 %id) | |||
BQ644436 | hepatocellular carcinoma, cell line, Liver | .h | 579 to 1464 | 1 to 891 | exact | tiling clone, | 891/893 (99 %) | 16 diff (98.3 %id) | |
BQ652209 | hepatocellular carcinoma, cell line, Liver | .h | 577 to 1298 | 10 to 739 | exact | tiling clone, | 730/912 (80 %) | 16 diff (98.3 %id) | |
BQ680593 | melanotic melanoma, cell line, skin | .a | 832 to 1734 | 1 to 907 | 907/907 (100 %) | 16 diff (98.3 %id) | |||
BQ881490 | melanotic melanoma, cell line, skin | .a | 1250 to 1948 | 1 to 702 | 702/979 (71 %) | 10 diff (99.0 %id) | |||
BQ649575 | hepatocellular carcinoma, cell line, Liver | .h | 579 to 1248 | 1 to 673 | E102K | 673/974 (69 %) | 17 diff (98.3 %id) | ||
BQ654116 | hepatocellular carcinoma, cell line, Liver | .h | 579 to 1236 | 1 to 657 | exact | 657/991 (66 %) | 5 diff (99.5 %id) | ||
BQ646344 | hepatocellular carcinoma, cell line, Liver | .h | 579 to 1232 | 1 to 655 | exact | 655/972 (67 %) | 18 diff (98.2 %id) | ||
BU595628 | mixed (pool of 40 RNAs) | .a | 1037 to 1749 | 1 to 713 | 713/713 (100 %) | 4 diff (99.5 %id) | |||
BQ938264 | leiomyosarcoma, uterus | .a | 535 to 1406 | 9 to 891 | 880/952 (92 %) | 33 diff (96.6 %id) | |||
BQ920263 | carcinoma, cell line, Prostate | .a | 1030 to 1865 | 37 to 884 | 848/988 (85 %) | 33 diff (96.7 %id) | |||
BU602289 | mixed (pool of 40 RNAs) | .a | 1212 to 1982 | 1 to 783 | 783/784 (99 %) | 18 diff (97.8 %id) | |||
BU538002 | adenocarcinoma, cell line, breast | .a | 1302 to 2167 | 1 to 880 | 880/932 (94 %) | 4 diff (99.6 %id) | |||
BU541195 | carcinoma, cell line, Prostate | .e | 741 to 1454 | 755 to 39 | AAA | Submitted on the opposite strand | 717/899 (79 %) | 17 diff (98.2 %id) | |
BU543838 | carcinoma, cell line, Prostate | .e | 730 to 1454 | 764 to 39 | AAA | Submitted on the opposite strand | 726/845 (85 %) | 12 diff (98.6 %id) | |
BU553077 | ovary, teratocarcinoma, cell line | .a | 360 to 1163 | 1 to 810 | 810/867 (93 %) | 39 diff (95.6 %id) | |||
BU849078 | ovary, teratocarcinoma, cell line | .c | 99 to 584 | 1 to 499 | 499/900 (55 %) | 17 diff (98.2 %id) | |||
BU849586 | ovary, teratocarcinoma, cell line | .a | 370 to 1064 | 1 to 704 | 704/865 (81 %) | 15 diff (98.3 %id) | |||
BU855508 | ovary, teratocarcinoma, cell line | .a | 370 to 1043 | 1 to 674 | 674/884 (76 %) | 9 diff (99.0 %id) | |||
BU856878 | adenocarcinoma, cell line, breast | .a | 896 to 1653 | 1 to 765 | 765/951 (80 %) | 9 diff (99.1 %id) | |||
BU857053 | adenocarcinoma, cell line, breast | .e | 771 to 1453 | 1 to 682 | AAA | 682/682 (100 %) | 2 diff (99.8 %id) | ||
CA487244 | .a | 817 to 1760 | 30 to 973 | 944/973 (97 %) | 24 diff (97.6 %id) | ||||
CA454247 | .a | 1155 to 1996 | 1 to 847 | 847/898 (94 %) | 9 diff (99.0 %id) | ||||
CA488894 | .a | 1013 to 1874 | 1 to 870 | 870/882 (98 %) | 13 diff (98.6 %id) | ||||
CA489617 | .a | 1032 to 1912 | 1 to 890 | 890/899 (98 %) | 20 diff (97.8 %id) | ||||
BU943899 | adenocarcinoma, cell line, breast | .a | 896 to 1696 | 1 to 808 | 808/920 (87 %) | 20 diff (97.9 %id) | |||
BU956641 | adenocarcinoma, cell line, breast | .a | 1355 to 2031 | 1 to 680 | 680/928 (73 %) | 9 diff (99.1 %id) | |||
CX867015 | embryonic stem | .a | 414 to 1110 | 1 to 697 | Submitted on the opposite strand | 697/697 (100 %) | 0 diff (100 %id) | ||
CX867069 | embryonic stem | .e | 1288 to 1453 | 192 to 27 | AAA | Submitted on the opposite strand | 166/166 (100 %) | 0 diff (100 %id) | |
CV810155 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .e | 749 to 1453 | 724 to 20 | AAA | Submitted on the opposite strand | 705/705 (100 %) | 4 diff (99.5 %id) | |
CD244789 | White Matter | .a | 917 to 1777 | 1 to 866 | 866/873 (99 %) | 15 diff (98.3 %id) | |||
CD171953 | White Matter | .a | 908 to 1715 | 1 to 813 | 813/892 (91 %) | 13 diff (98.6 %id) | |||
CD557209 | testis | .a | 759 to 1523 | 1 to 766 | 766/885 (86 %) | 10 diff (98.9 %id) | |||
BC065834 | testis | .c | 247 to 1965 | 1 to 1719 | exact | tiling clone, available from MGC, AAA | 1719/1719 (100 %) | 2 diff (99.9 %id) | |
CF128594 | Chondrosarcoma Lung Metastasis cell lines, lung | .a | 883 to 1686 | 1 to 800 | 800/800 (100 %) | 7 diff (99.2 %id) | |||
CF126329 | Chondrosarcoma Lung Metastasis cell lines, lung | .a | 1133 to 1879 | 1 to 747 | 747/747 (100 %) | 4 diff (99.5 %id) | |||
TI_57196648 | .a | 1097 to 1890 | 29 to 823 | 795/823 (96 %) | 13 diff (98.5 %id) | ||||
TI_57203021 | .a | 1097 to 1947 | 63 to 909 | 847/926 (91 %) | 14 diff (98.5 %id) | ||||
TI_57171044 | .b | 24 to 365 | 25 to 368 | 344/510 (67 %) | 13 diff (97.5 %id) | ||||
TI_45133655 | .a | 1206 to 1947 | 58 to 794 | 737/737 (100 %) | 11 diff (98.6 %id) | ||||
TI_57230839 | .b | 1122 to 1835 | 52 to 765 | 714/714 (100 %) | 3 diff (99.6 %id) | ||||
TI_59384511 | .b | 1122 to 1903 | 48 to 830 | 783/832 (94 %) | 20 diff (97.6 %id) | ||||
TI_59380396 | .a | 805 to 1681 | 60 to 935 | 876/877 (99 %) | 19 diff (97.9 %id) | ||||
TI_59382400 | .a | 805 to 1553 | 101 to 861 | 761/779 (97 %) | 16 diff (98.0 %id) | ||||
TI_59393746 | .a | 1047 to 1886 | 82 to 922 | 841/844 (99 %) | 19 diff (97.8 %id) | ||||
TI_59394085 | .a | 1031 to 1886 | 91 to 953 | 863/865 (99 %) | 17 diff (98.1 %id) | ||||
TI_59394735 | .a | 804 to 1695 | 86 to 983 | 898/899 (99 %) | 23 diff (97.5 %id) | ||||
TI_59390284 | .a | 993 to 1891 | 100 to 1002 | 903/910 (99 %) | 29 diff (96.9 %id) | ||||
CB128252 | Liver | .a | 1101 to 1445 | 1 to 345 | 345/345 (100 %) | 0 diff (100 %id) | |||
CB141462 | Liver | .b | 1043 to 1647 | 1 to 605 | tiling clone, | 605/605 (100 %) | 1 diff (99.9 %id) | ||
CB149178 | Liver | .a | 932 to 1584 | 1 to 653 | 653/653 (100 %) | 2 diff (99.7 %id) | |||
NM_000837.1 | .c | 1 to 1968 | 1 to 1968 | exact | RefSeq, AAA | 1968/1968 (100 %) | 1 diff (100.0 %id) | ||
NM_001009184.1 | .a | 315 to 2170 | 1 to 1856 | RefSeq, AAA | 1856/1856 (100 %) | 1 diff (100.0 %id) | |||
DA683763 | .a | 314 to 825 | 2 to 513 | capped | 512/512 (100 %) | 0 diff (100 %id) | |||
DA699852 | .a | 314 to 630 | 2 to 318 | capped | 317/317 (100 %) | 0 diff (100 %id) | |||
CV570438 | cornea, eye | .e | 1302 to 1454 | 175 to 23 | AAA | Submitted on the opposite strand | 153/153 (100 %) | 0 diff (100 %id) | |
CR988408 | T-Lymphocytes | .d | 1 to 796 | 1 to 796 | L62V D241X | tiling clone, | 796/796 (100 %) | 1 diff (99.9 %id) | |
BM756553 | Ascites, stomach | .a | 984 to 1300 | 1 to 317 | 317/317 (100 %) | 0 diff (100 %id) | |||
BM742751 | stomach | .a | 789 to 1392 | 1 to 604 | 604/604 (100 %) | 0 diff (100 %id) | |||
BM764440 | stomach | .a | 789 to 1391 | 1 to 603 | 603/603 (100 %) | 0 diff (100 %id) | |||
BM764483 | stomach | .a | 789 to 1497 | 1 to 708 | 708/708 (100 %) | 2 diff (99.8 %id) | |||
BM765292 | stomach | .a | 789 to 1497 | 1 to 709 | 709/709 (100 %) | 1 diff (99.9 %id) | |||
BM762447 | myeloma | .c | 83 to 686 | 1 to 604 | 604/604 (100 %) | 0 diff (100 %id) | |||
BM762895 | myeloma | .c | 83 to 587 | 1 to 505 | 505/505 (100 %) | 0 diff (100 %id) | |||
T30302 | testis | .e | 1223 to 1453 | 231 to 1 | 231/231 (100 %) | 0 diff (100 %id) | |||
DB004886 | breast, tumor tissue | .a | 314 to 580 | 2 to 268 | capped | 267/267 (100 %) | 0 diff (100 %id) | ||
DB023080 | testis | .a | 392 to 722 | 2 to 332 | capped | 331/331 (100 %) | 0 diff (100 %id) | ||
DB026655 | testis | .a | 397 to 792 | 2 to 397 | capped | 396/396 (100 %) | 0 diff (100 %id) | ||
DB027094 | testis | .a | 427 to 776 | 2 to 351 | capped | 350/350 (100 %) | 0 diff (100 %id) | ||
DB033028 | testis | .b | 1 to 557 | 2 to 558 | tiling clone, capped | 557/557 (100 %) | 0 diff (100 %id) | ||
DB035271 | testis | .a | 315 to 612 | 2 to 299 | capped | 298/298 (100 %) | 0 diff (100 %id) | ||
DB105953 | thymus | .a | 314 to 585 | 2 to 273 | capped | 272/272 (100 %) | 0 diff (100 %id) | ||
DB129491 | thymus | .g-u | 1 to 539 | 2 to 540 | exact | tiling clone, capped | 539/539 (100 %) | 0 diff (100 %id) | |
TI_154047658 | .e | 729 to 1453 | 811 to 86 | AAA | 726/978 (74 %) | 31 diff (96.9 %id) | |||
TI_154121004 | .e | 726 to 1453 | 802 to 76 | AAA | 727/957 (75 %) | 13 diff (98.7 %id) | |||
TI_154189299 | .a | 1132 to 1930 | 50 to 846 | 797/984 (80 %) | 13 diff (98.7 %id) | ||||
TI_154194708 | .a | 882 to 1801 | 50 to 953 | 904/1017 (88 %) | 24 diff (97.7 %id) | ||||
TI_159686569 | .a | 1182 to 2167 | 1012 to 32 | AAA | 981/1045 (93 %) | 22 diff (97.9 %id) | |||
TI_159712541 | .b | 1113 to 2111 | 1077 to 90 | tiling clone, AAA | 988/1063 (92 %) | 29 diff (97.3 %id) | |||
CB851934 | Human Lung Epithelial cells, lung | .e | 736 to 1454 | 736 to 19 | AAA | 718/718 (100 %) | 6 diff (99.2 %id) | ||
CA312848 | Human Lung Epithelial cells, lung | .e | 730 to 1453 | 742 to 19 | AAA | 724/724 (100 %) | 2 diff (99.8 %id) | ||
BM708216 | eye, RPE and Choroid | .e | 740 to 1001 | 1 to 263 | fully sequenced, | 263/263 (100 %) | 1 diff (99.7 %id) | ||
BU732058 | eye, RPE and Choroid | .e | 971 to 1453 | 501 to 19 | fully sequenced, AAA | 483/483 (100 %) | 1 diff (99.8 %id) | ||
BM662184 | eye, human retina | .e | 1281 to 1453 | 191 to 19 | AAA | 173/173 (100 %) | 0 diff (100 %id) | ||
CA445050 | lung, Metastatic Chondrosarcoma | .e | 1284 to 1453 | 188 to 19 | AAA | 170/170 (100 %) | 0 diff (100 %id) | ||
BU620810 | cell lines, Chondrosarcoma | .e | 1284 to 1453 | 188 to 19 | AAA | 170/170 (100 %) | 0 diff (100 %id) | ||
BU634008 | cell lines, Chondrosarcoma | .e | 783 to 1454 | 691 to 19 | AAA | 673/673 (100 %) | 5 diff (99.3 %id) | ||
CA308514 | Alveolar Macrophage, lung | .e | 733 to 1450 | 735 to 19 | AAA | 717/717 (100 %) | 5 diff (99.4 %id) | ||
CD369925 | Alveolar Macrophage, lung | .e | 736 to 1453 | 736 to 19 | AAA | 718/718 (100 %) | 3 diff (99.6 %id) | ||
BQ679688 | melanotic melanoma, cell line, skin | .a | 808 to 1596 | 1 to 795 | 795/911 (87 %) | 14 diff (98.5 %id) | |||
BQ648539 | hepatocellular carcinoma, cell line, Liver | .h | 579 to 1344 | 1 to 782 | exact | tiling clone, | 782/907 (86 %) | 32 diff (96.5 %id) | |
BQ648539 | IMAGE:6271458 | GRINA.hAug10 | 1344 | 782 | IMAGE:6271458 | 782 | 32 | ||
BQ678145 | IMAGE:6274379 | GRINA.aAug10 | 1669 | 874 | IMAGE:6274379 | 874 | 29 | ||
BQ678145 | IMAGE:6274379 | GRINA.aAug10 | 1669 | 874 | IMAGE:6274379 | 874 | 29 | ||
BQ673268 | IMAGE:6275311 | GRINA.aAug10 | 1995 | 908 | IMAGE:6275311 | 908 | 38 | ||
BQ673268 | IMAGE:6275311 | GRINA.aAug10 | 1995 | 908 | IMAGE:6275311 | 908 | 38 | ||
BQ706845 | IMAGE:6281573 | GRINA.aAug10 | 1892 | 814 | IMAGE:6281573 | 814 | 18 | ||
BQ708671 | IMAGE:6282417 | GRINA.aAug10 | 1874 | 818 | IMAGE:6282417 | 801 | 23 | ||
BQ644436 | IMAGE:6285573 | GRINA.hAug10 | 1464 | 891 | IMAGE:6285573 | 891 | 16 | ||
BQ644436 | IMAGE:6285573 | GRINA.hAug10 | 1464 | 891 | IMAGE:6285573 | 891 | 16 | ||
BQ652209 | IMAGE:6286520 | GRINA.hAug10 | 1298 | 739 | IMAGE:6286520 | 730 | 16 | ||
BQ652209 | IMAGE:6286520 | GRINA.hAug10 | 1298 | 739 | IMAGE:6286520 | 730 | 16 | ||
BQ680593 | IMAGE:6294641 | GRINA.aAug10 | 1734 | 907 | IMAGE:6294641 | 907 | 16 | ||
BQ680593 | IMAGE:6294641 | GRINA.aAug10 | 1734 | 907 | IMAGE:6294641 | 907 | 16 | ||
BQ881490 | IMAGE:6295195 | GRINA.aAug10 | 1948 | 702 | IMAGE:6295195 | 702 | 10 | ||
BQ881490 | IMAGE:6295195 | GRINA.aAug10 | 1948 | 702 | IMAGE:6295195 | 702 | 10 | ||
BQ649575 | IMAGE:6296219 | GRINA.hAug10 | 1248 | 673 | IMAGE:6296219 | 673 | 17 | ||
BQ649575 | IMAGE:6296219 | GRINA.hAug10 | 1248 | 673 | IMAGE:6296219 | 673 | 17 | ||
BQ654116 | IMAGE:6296443 | GRINA.hAug10 | 1236 | 657 | IMAGE:6296443 | 657 | 5 | ||
BQ654116 | IMAGE:6296443 | GRINA.hAug10 | 1236 | 657 | IMAGE:6296443 | 657 | 5 | ||
BQ646344 | IMAGE:6299456 | GRINA.hAug10 | 1232 | 655 | IMAGE:6299456 | 655 | 18 | ||
BQ646344 | IMAGE:6299456 | GRINA.hAug10 | 1232 | 655 | IMAGE:6299456 | 655 | 18 | ||
BU595628 | IMAGE:6451483 | GRINA.aAug10 | 1749 | 713 | IMAGE:6451483 | 713 | 4 | ||
BQ938264 | IMAGE:6471502 | GRINA.aAug10 | 1406 | 891 | IMAGE:6471502 | 880 | 33 | ||
BQ938264 | IMAGE:6471502 | GRINA.aAug10 | 1406 | 891 | IMAGE:6471502 | 880 | 33 | ||
BQ920263 | IMAGE:6481701 | GRINA.aAug10 | 1865 | 884 | IMAGE:6481701 | 848 | 33 | ||
BQ920263 | IMAGE:6481701 | GRINA.aAug10 | 1865 | 884 | IMAGE:6481701 | 848 | 33 | ||
BU602289 | IMAGE:6496352 | GRINA.aAug10 | 1982 | 783 | IMAGE:6496352 | 783 | 18 | ||
BU538002 | IMAGE:6568509 | GRINA.aAug10 | 2167 | 880 | IMAGE:6568509 | 880 | 4 | ||
BU538002 | IMAGE:6568509 | GRINA.aAug10 | 2167 | 880 | IMAGE:6568509 | 880 | 4 | ||
BU541195 | IMAGE:6572815 | GRINA.eAug10 | 1454 | 39 | IMAGE:6572815 | Inverted | 717 | 17 | |
BU541195 | IMAGE:6572815 | GRINA.eAug10 | 1454 | 39 | IMAGE:6572815 | Inverted | 717 | 17 | |
BU543838 | IMAGE:6576022 | GRINA.eAug10 | 1454 | 39 | IMAGE:6576022 | Inverted | 726 | 12 | |
BU543838 | IMAGE:6576022 | GRINA.eAug10 | 1454 | 39 | IMAGE:6576022 | Inverted | 726 | 12 | |
BU553077 | IMAGE:6577359 | GRINA.aAug10 | 1163 | 810 | IMAGE:6577359 | 810 | 39 | ||
BU553077 | IMAGE:6577359 | GRINA.aAug10 | 1163 | 810 | IMAGE:6577359 | 810 | 39 | ||
BU849078 | IMAGE:6597362 | GRINA.cAug10 | 584 | 499 | IMAGE:6597362 | 499 | 17 | ||
BU849078 | IMAGE:6597362 | GRINA.cAug10 | 584 | 499 | IMAGE:6597362 | 499 | 17 | ||
BU849586 | IMAGE:6598211 | GRINA.aAug10 | 1064 | 704 | IMAGE:6598211 | 704 | 15 | ||
BU849586 | IMAGE:6598211 | GRINA.aAug10 | 1064 | 704 | IMAGE:6598211 | 704 | 15 | ||
BU855508 | IMAGE:6645017 | GRINA.aAug10 | 1043 | 674 | IMAGE:6645017 | 674 | 9 | ||
BU855508 | IMAGE:6645017 | GRINA.aAug10 | 1043 | 674 | IMAGE:6645017 | 674 | 9 | ||
BU856878 | IMAGE:6646663 | GRINA.aAug10 | 1653 | 765 | IMAGE:6646663 | 765 | 9 | ||
BU856878 | IMAGE:6646663 | GRINA.aAug10 | 1653 | 765 | IMAGE:6646663 | 765 | 9 | ||
BU857053 | IMAGE:6646856 | GRINA.eAug10 | 1453 | 682 | IMAGE:6646856 | 682 | 2 | ||
BU857053 | IMAGE:6646856 | GRINA.eAug10 | 1453 | 682 | IMAGE:6646856 | 682 | 2 | ||
CA487244 | IMAGE:6718296 | GRINA.aAug10 | 1760 | 973 | IMAGE:6718296 | 944 | 24 | ||
CA454247 | IMAGE:6718916 | GRINA.aAug10 | 1996 | 847 | IMAGE:6718916 | 847 | 9 | ||
CA488894 | IMAGE:6721099 | GRINA.aAug10 | 1874 | 870 | IMAGE:6721099 | 870 | 13 | ||
CA489617 | IMAGE:6722095 | GRINA.aAug10 | 1912 | 890 | IMAGE:6722095 | 890 | 20 | ||
BU943899 | IMAGE:6728093 | GRINA.aAug10 | 1696 | 808 | IMAGE:6728093 | 808 | 20 | ||
BU943899 | IMAGE:6728093 | GRINA.aAug10 | 1696 | 808 | IMAGE:6728093 | 808 | 20 | ||
BU956641 | IMAGE:6730255 | GRINA.aAug10 | 2031 | 680 | IMAGE:6730255 | 680 | 9 | ||
BU956641 | IMAGE:6730255 | GRINA.aAug10 | 2031 | 680 | IMAGE:6730255 | 680 | 9 | ||
CX867015 | IMAGE:7472165 | GRINA.aAug10 | 1110 | 697 | IMAGE:7472165 | Inverted | 697 | 0 | |
CX867069 | IMAGE:7472165__1 | GRINA.eAug10 | 1453 | 27 | IMAGE:7472165__1 | Inverted | 166 | 0 | |
CV810155 | IMAGE:7501619 | GRINA.eAug10 | 1453 | 20 | IMAGE:7501619 | Inverted | 705 | 4 | |
CV810155 | IMAGE:7501619 | GRINA.eAug10 | 1453 | 20 | IMAGE:7501619 | Inverted | 705 | 4 | |
CD244789 | IMAGE:30376437 | GRINA.aAug10 | 1777 | 866 | IMAGE:30376437 | 866 | 15 | ||
CD171953 | IMAGE:30377321 | GRINA.aAug10 | 1715 | 813 | IMAGE:30377321 | 813 | 13 | ||
CD557209 | IMAGE:30387301 | GRINA.aAug10 | 1523 | 766 | IMAGE:30387301 | 766 | 10 | ||
BC065834 | IMAGE:30389112 | GRINA.cAug10 | 1965 | 1719 | IMAGE:30389112 | 1719 | 2 | ||
CF128594 | IMAGE:30557743 | GRINA.aAug10 | 1686 | 800 | IMAGE:30557743 | 800 | 7 | ||
CF128594 | IMAGE:30557743 | GRINA.aAug10 | 1686 | 800 | IMAGE:30557743 | 800 | 7 | ||
CF126329 | IMAGE:30560290 | GRINA.aAug10 | 1879 | 747 | IMAGE:30560290 | 747 | 4 | ||
CF126329 | IMAGE:30560290 | GRINA.aAug10 | 1879 | 747 | IMAGE:30560290 | 747 | 4 | ||
TI_57196648 | INCYTE_603033361 | GRINA.aAug10 | 1890 | 823 | INCYTE_603033361 | 795 | 13 | ||
TI_57203021 | INCYTE_603041482 | GRINA.aAug10 | 1947 | 909 | INCYTE_603041482 | 847 | 14 | ||
TI_57171044 | INCYTE_603073013 | GRINA.bAug10 | 365 | 368 | INCYTE_603073013 | 344 | 13 | ||
TI_45133655 | INCYTE_603185738 | GRINA.aAug10 | 1947 | 794 | INCYTE_603185738 | 737 | 11 | ||
TI_57230839 | INCYTE_603395606 | GRINA.bAug10 | 1835 | 765 | INCYTE_603395606 | 714 | 3 | ||
TI_59384511 | INCYTE_603630373 | GRINA.bAug10 | 1903 | 830 | INCYTE_603630373 | 783 | 20 | ||
TI_59380396 | INCYTE_603635388 | GRINA.aAug10 | 1681 | 935 | INCYTE_603635388 | 876 | 19 | ||
TI_59382400 | INCYTE_603638008 | GRINA.aAug10 | 1553 | 861 | INCYTE_603638008 | 761 | 16 | ||
TI_59393746 | INCYTE_603641713 | GRINA.aAug10 | 1886 | 922 | INCYTE_603641713 | 841 | 19 | ||
TI_59394085 | INCYTE_603642081 | GRINA.aAug10 | 1886 | 953 | INCYTE_603642081 | 863 | 17 | ||
TI_59394735 | INCYTE_603642809 | GRINA.aAug10 | 1695 | 983 | INCYTE_603642809 | 898 | 23 | ||
TI_59390284 | INCYTE_603647840 | GRINA.aAug10 | 1891 | 1002 | INCYTE_603647840 | 903 | 29 | ||
CB128252 | L11SNU354-14-H03 | GRINA.aAug10 | 1445 | 345 | L11SNU354-14-H03 | 345 | 0 | ||
CB141462 | L15CKK1-26-D03 | GRINA.bAug10 | 1647 | 605 | L15CKK1-26-D03 | 605 | 1 | ||
CB149178 | L15CKK1-35-H12 | GRINA.aAug10 | 1584 | 653 | L15CKK1-35-H12 | 653 | 2 | ||
NM_000837.1 | NM_000837 | GRINA.cAug10 | 1968 | 1968 | NM_000837 | 1968 | 1 | ||
NM_001009184.1 | NM_001009184 | GRINA.aAug10 | 2170 | 1856 | NM_001009184 | 1856 | 1 | ||
DA683763 | NT2NE2001065 | GRINA.aAug10 | 825 | 513 | NT2NE2001065 | 512 | 0 | ||
DA699852 | NT2RI2002126 | GRINA.aAug10 | 630 | 318 | NT2RI2002126 | 317 | 0 | ||
CV570438 | oe01b09 | GRINA.eAug10 | 1454 | 23 | oe01b09 | Inverted | 153 | 0 | |
CV570438 | oe01b09 | GRINA.eAug10 | 1454 | 23 | oe01b09 | Inverted | 153 | 0 | |
CR988408 | RZPDp9016P0943 | GRINA.dAug10 | 796 | 796 | RZPDp9016P0943 | 796 | 1 | ||
BM756553 | S2SNU668-21-H01 | GRINA.aAug10 | 1300 | 317 | S2SNU668-21-H01 | 317 | 0 | ||
BM756553 | S2SNU668-21-H01 | GRINA.aAug10 | 1300 | 317 | S2SNU668-21-H01 | 317 | 0 | ||
BM742751 | S7SNU719-9-F07 | GRINA.aAug10 | 1392 | 604 | S7SNU719-9-F07 | 604 | 0 | ||
BM764440 | S7SNU719s1-2-D01 | GRINA.aAug10 | 1391 | 603 | S7SNU719s1-2-D01 | 603 | 0 | ||
BM764483 | S7SNU719s1-2-G11 | GRINA.aAug10 | 1497 | 708 | S7SNU719s1-2-G11 | 708 | 2 | ||
BM765292 | S7SNU719s1-3-F10 | GRINA.aAug10 | 1497 | 709 | S7SNU719s1-3-F10 | 709 | 1 | ||
BM762447 | S13KMS5-11-E10 | GRINA.cAug10 | 686 | 604 | S13KMS5-11-E10 | 604 | 0 | ||
BM762895 | S13KMS5-13-A11 | GRINA.cAug10 | 587 | 505 | S13KMS5-13-A11 | 505 | 0 | ||
T30302 | T30302 | GRINA.eAug10 | 1453 | 1 | T30302 | 231 | 0 | ||
DB004886 | TBAES2007754 | GRINA.aAug10 | 580 | 268 | TBAES2007754 | 267 | 0 | ||
DB023080 | TESTI2004193 | GRINA.aAug10 | 722 | 332 | TESTI2004193 | 331 | 0 | ||
DB026655 | TESTI2008916 | GRINA.aAug10 | 792 | 397 | TESTI2008916 | 396 | 0 | ||
DB027094 | TESTI2009487 | GRINA.aAug10 | 776 | 351 | TESTI2009487 | 350 | 0 | ||
DB033028 | TESTI2017675 | GRINA.bAug10 | 557 | 558 | TESTI2017675 | 557 | 0 | ||
DB035271 | TESTI2020589 | GRINA.aAug10 | 612 | 299 | TESTI2020589 | 298 | 0 | ||
DB105953 | THYMU2006998 | GRINA.aAug10 | 585 | 273 | THYMU2006998 | 272 | 0 | ||
DB129491 | THYMU2039869 | GRINA.gAug10-unspliced | 539 | 540 | THYMU2039869 | 539 | 0 | ||
TI_154047658 | TI_154047658 | GRINA.eAug10 | 1453 | 86 | TI_154047658 | 726 | 31 | ||
TI_154121004 | TI_154121004 | GRINA.eAug10 | 1453 | 76 | TI_154121004 | 727 | 13 | ||
TI_154189299 | TI_154189299 | GRINA.aAug10 | 1930 | 846 | TI_154189299 | 797 | 13 | ||
TI_154194708 | TI_154194708 | GRINA.aAug10 | 1801 | 953 | TI_154194708 | 904 | 24 | ||
TI_159686569 | TI_159686569 | GRINA.aAug10 | 2167 | 32 | TI_159686569 | 981 | 22 | ||
TI_159712541 | TI_159712541 | GRINA.bAug10 | 2111 | 90 | TI_159712541 | 988 | 29 | ||
CB851934 | UI-CF-FN0-aeu-d-10-0-UI | GRINA.eAug10 | 1454 | 19 | UI-CF-FN0-aeu-d-10-0-UI | 718 | 6 | ||
CB851934 | UI-CF-FN0-aeu-d-10-0-UI | GRINA.eAug10 | 1454 | 19 | UI-CF-FN0-aeu-d-10-0-UI | 718 | 6 | ||
CA312848 | UI-CF-FN0-afl-b-02-0-UI | GRINA.eAug10 | 1453 | 19 | UI-CF-FN0-afl-b-02-0-UI | 724 | 2 | ||
CA312848 | UI-CF-FN0-afl-b-02-0-UI | GRINA.eAug10 | 1453 | 19 | UI-CF-FN0-afl-b-02-0-UI | 724 | 2 | ||
BM708216 | UI-E-CI1-aft-n-04-0-UI | GRINA.eAug10 | 1001 | 263 | UI-E-CI1-aft-n-04-0-UI | 263 | 1 | ||
BM708216 | UI-E-CI1-aft-n-04-0-UI | GRINA.eAug10 | 1001 | 263 | UI-E-CI1-aft-n-04-0-UI | 263 | 1 | ||
BU732058 | UI-E-CI1-aft-n-04-0-UI | GRINA.eAug10 | 1453 | 19 | UI-E-CI1-aft-n-04-0-UI | 483 | 1 | ||
BU732058 | UI-E-CI1-aft-n-04-0-UI | GRINA.eAug10 | 1453 | 19 | UI-E-CI1-aft-n-04-0-UI | 483 | 1 | ||
BM662184 | UI-E-CL0-acd-d-05-0-UI | GRINA.eAug10 | 1453 | 19 | UI-E-CL0-acd-d-05-0-UI | 173 | 0 | ||
BM662184 | UI-E-CL0-acd-d-05-0-UI | GRINA.eAug10 | 1453 | 19 | UI-E-CL0-acd-d-05-0-UI | 173 | 0 | ||
CA445050 | UI-H-DT1-awn-g-09-0-UI | GRINA.eAug10 | 1453 | 19 | UI-H-DT1-awn-g-09-0-UI | 170 | 0 | ||
CA445050 | UI-H-DT1-awn-g-09-0-UI | GRINA.eAug10 | 1453 | 19 | UI-H-DT1-awn-g-09-0-UI | 170 | 0 | ||
BU620810 | UI-H-FL1-bfx-h-18-0-UI | GRINA.eAug10 | 1453 | 19 | UI-H-FL1-bfx-h-18-0-UI | 170 | 0 | ||
BU620810 | UI-H-FL1-bfx-h-18-0-UI | GRINA.eAug10 | 1453 | 19 | UI-H-FL1-bfx-h-18-0-UI | 170 | 0 | ||
BU634008 | UI-H-FL1-bgw-k-20-0-UI | GRINA.eAug10 | 1454 | 19 | UI-H-FL1-bgw-k-20-0-UI | 673 | 5 | ||
BU634008 | UI-H-FL1-bgw-k-20-0-UI | GRINA.eAug10 | 1454 | 19 | UI-H-FL1-bgw-k-20-0-UI | 673 | 5 | ||
CA308514 | UI-H-FT1-bhz-p-20-0-UI | GRINA.eAug10 | 1450 | 19 | UI-H-FT1-bhz-p-20-0-UI | 717 | 5 | ||
CA308514 | UI-H-FT1-bhz-p-20-0-UI | GRINA.eAug10 | 1450 | 19 | UI-H-FT1-bhz-p-20-0-UI | 717 | 5 | ||
CD369925 | UI-H-FT1-bke-e-20-0-UI | GRINA.eAug10 | 1453 | 19 | UI-H-FT1-bke-e-20-0-UI | 718 | 3 | ||
CD369925 | UI-H-FT1-bke-e-20-0-UI | GRINA.eAug10 | 1453 | 19 | UI-H-FT1-bke-e-20-0-UI | 718 | 3 |
? | Gene Summary | Gene on genome | mRNA:.a, .b, .c, .d, .e, .f, .g-u, .h | Alternative mRNAs features, proteins, introns, exons, sequences | Expression Tissue | Function, regulation, related genes DC |